Autopsy report · NCT02156843
Pyridorin in Diabetic Nephropathy
Cause of deathNo reason given
Life of this trial
- Ran for about 3 years 9 months before it stopped.
- 328 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- NephroGenex, Inc.
- Sponsor type
- Industry
- Conditions
- Diabetic Nephropathy; Diabetic Kidney Disease
- Interventions
- Pyridorin; Placebo
- Participants
- 328
- Sites
- 137
- Countries
- Australia, Bulgaria, France, Germany, Hong Kong, Hungary, Israel, Mauritius, Poland, Puerto Rico, Spain, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.